CA125 is elevated in 85% of serous, 65% of endometrioid, 40% of clear‐cell, 36% of undifferentiated, and only 12% of mucinous ovarian carcinomas (Hogdall et al. 2007). The gene discussed is MUC16; the disease is ovarian mucinous adenocarcinoma.